These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9802271)

  • 1. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.
    Zwarenstein M; Schoeman JH; Vundule C; Lombard CJ; Tatley M
    Lancet; 1998 Oct; 352(9137):1340-3. PubMed ID: 9802271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis treatment delivery in high burden settings: does patient choice of supervision matter?
    Kironde S; Meintjies M
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):599-608. PubMed ID: 12102299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct observation and completion of treatment of tuberculosis in rural areas of China.
    Jianming Wang ; Hongbinh Shen
    Scand J Public Health; 2009 May; 37(3):304-9. PubMed ID: 19286750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.
    Jasmer RM; Seaman CB; Gonzalez LC; Kawamura LM; Osmond DH; Daley CL
    Am J Respir Crit Care Med; 2004 Sep; 170(5):561-6. PubMed ID: 15184210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis.
    Zwarenstein M; Schoeman JH; Vundule C; Lombard CJ; Tatley M
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):550-4. PubMed ID: 10864186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lay health worker intervention with choice of DOT superior to standard TB care for farm dwellers in South Africa: a cluster randomised control trial.
    Clarke M; Dick J; Zwarenstein M; Lombard CJ; Diwan VK
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):673-9. PubMed ID: 15971396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from a randomised clinical trial for multidrug-resistant tuberculosis.
    Padayatchi N; Mac Kenzie WR; Hirsch-Moverman Y; Feng PJ; Villarino E; Saukkonen J; Heilig CM; Weiner M; El-Sadr WM
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1582-7. PubMed ID: 23131255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
    Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM
    Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia.
    Mawer C; Ignatenko N; Wares D; Strelis A; Golubchikova V; Yanova G; Lyagoshina T; Sharaburova O; Banatvala N
    Lancet; 2001 Aug; 358(9280):445-9. PubMed ID: 11513907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis.
    Weis SE; Slocum PC; Blais FX; King B; Nunn M; Matney GB; Gomez E; Foresman BH
    N Engl J Med; 1994 Apr; 330(17):1179-84. PubMed ID: 8139628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan.
    Walley JD; Khan MA; Newell JN; Khan MH
    Lancet; 2001 Mar; 357(9257):664-9. PubMed ID: 11247549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.
    Leimane V; Riekstina V; Holtz TH; Zarovska E; Skripconoka V; Thorpe LE; Laserson KF; Wells CD
    Lancet; 2005 Jan 22-28; 365(9456):318-26. PubMed ID: 15664227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.